Katarina Ondacova

Katarina Ondacova

Auto-generated profile, based on publicly available information

Katarina Ondacova

Center of Biosciences, Institute of Molecular Physiology and Genetics, Slovak Academy of Sciences, Bratislava, Slovakia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2016 in Channels
Verified
Journal Article
Open access
KOKatarina Ondacova
Katarina Ondacova
MKMaria Karmazinova
Maria Karmazinova
JLJoanna Lazniewska
Joanna Lazniewska
Norbert WeissNorbert Weiss
Norbert Weiss
ĽLĽubica Lacinová
Ľubica Lacinová
Low-voltage-gated T-type calcium channels are expressed throughout the nervous system where they play an essential role in shaping neuronal excitability. Defects in T-type channel expression have been linked to various neuronal disorders including neuropathic pain and epilepsy. Currently, little is known about the cellular mechanisms controlling the expression and function of T-type channels. Asparagine-linked glycosylation has recently emerged as an essential signaling pathway by which the cellular environment can control expression of T-type channels. However, the role of N-glycans in the conducting function of T-type channels remains elusive. In the present study, we used human Cav3.2 glycosylation-deficient channels to assess the role of N-glycosylation on the gating of the channel. Patch-clamp recordings of gating currents revealed that N-glycans attached to hCav3.2 channels have a minimal effect on the functioning of the channel voltage-sensor. In contrast, N-glycosylation on specific asparagine residues may have an essential role in the conducting function of the channel by enhancing the channel permeability and / or the pore opening of the channel. Our data suggest that modulation of N-linked glycosylation of hCav3.2 channels may play an important physiological role, and could also support the alteration of T-type currents observed in disease states.

10 April 2025 in Molecular Brain
Verified
Journal Article
Open access
PDF file
AFAlžbeta Filipová
Alžbeta Filipová
MTMatus Tomko
Matus Tomko
KOKatarina Ondacova
Katarina Ondacova
LHLucia Hoppanová
Lucia Hoppanová
Nikola ChmúrčiakováNikola Chmúrčiaková
Nikola Chmúrčiaková
ĽLĽubica Lacinová
Ľubica Lacinová
Elevated plasma homocysteine (Hcy) levels lead to hyperhomocysteinemia, a condition associated with various neurological disorders affecting multiple brain regions, including the hippocampus. In this study, we investigated the effects of exposing cultured rat hippocampal neurons to Hcy concentrations corresponding to mild, moderate, and severe hyperhomocysteinemia. A short 24-hour exposure had minimal effects, whereas prolonged exposure up to 14 days moderately enhanced hippocampal excitability without altering the gene expression of voltage-dependent calcium, sodium, or potassium channels or intracellular calcium levels. These findings suggest that Hcy-induced changes in neuronal excitability may contribute to neuropathologies associated with hyperhomocysteinemia.

31 March 2025 in Scientia Pharmaceutica
Verified
Journal Article
Open access
PDF file
LHLucia Hoppanová
Lucia Hoppanová
AFAlžbeta Filipová
Alžbeta Filipová
SBStanislava Bukatova
Stanislava Bukatova
KOKatarina Ondacova
Katarina Ondacova
MTMatus Tomko
Matus Tomko
ĽLĽubica Lacinová
Ľubica Lacinová
Maternal depression negatively affects the neurodevelopment of offspring, but its pharmacological treatment during gestation remains controversial. This study reports the consequences of maternal depression and/or prenatal antidepressant treatment with mirtazapine on offspring early neurodevelopment via an animal model of maternal depression induced by pregestational chronic unpredictable stress (CUS). Offspring from four groups were studied: nonstressed vehicle-treated dams, nonstressed mirtazapine-treated dams, stressed vehicle-treated dams, and stressed mirtazapine-treated dams. The hippocampal excitability of offspring was examined in primary hippocampal cultures established on the first postnatal day, reflecting mostly prenatal development, and in hippocampal slices prepared on postnatal days 11–13, reflecting an early postnatal development. The pregestational CUS modeling of maternal depression moderately suppressed offspring hippocampal excitability in primary cultures but facilitated it in slices. Mirtazapine administered to CUS-exposed dams partly rectified the changes observed in primary cultures of pups from untreated dams and, more prominently, in slices. Mirtazapine itself negatively affected the hippocampal excitability of nonstressed dam offspring in primary culture, and this effect was diminished in slices. Since altered hippocampal neurotransmission might be responsible, at least in part, for the neuropsychopathologies frequently observed in the offspring of depressed mothers, and mirtazapine was able to partly relieve such changes, this treatment may be also beneficial during the prenatal and perinatal periods.

24 January 2025 in Journal of Bioenergetics and Biomembranes
Verified
Journal Article
Open access
PDF file
MGMarian Grman
Marian Grman
MBMaria Balazova
Maria Balazova
AHAnton Horvath
Anton Horvath
KPKatarina Polcicova
Katarina Polcicova
KOKatarina Ondacova
Katarina Ondacova
ZTZuzana Sevcikova Tomaskova
Zuzana Sevcikova Tomaskova
Lithium is used in the long-term treatment of bipolar disorder, exhibiting a beneficial effect on the neuronal cells. The concentration of lithium in the blood serum can vary and can easily approach a level that is related to cardiotoxic adverse effects. This is due to its narrow therapeutic index. In this study, we investigated the effect of higher than therapeutic dose of lithium. Rat cardiomyoblast cells were treated with 2 mM LiCl for 48 h, after which the mitochondrial parameters of the cells were analyzed. Lithium exposure reduced maximal respiratory capacity by diminishing reserve respiratory capacity (RRC), linked to a decrease in complex I (NADH dehydrogenase) activity and elevated superoxide radical levels. In addition, lithium treatment altered the composition of cellular membranes, including mitochondrial cardiolipin, a lipid essential for mitochondrial function. These findings suggest that impaired complex I activity, oxidative stress, and cardiolipin depletion collectively impair the ability of cells to meet high energy demands.

28 January 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
LDLucia Dubiel-Hoppanova
Lucia Dubiel-Hoppanova
AFAlžbeta Filipová
Alžbeta Filipová
SBStanislava Bukatova
Stanislava Bukatova
KOKatarina Ondacova
Katarina Ondacova
MTMatus Tomko
Matus Tomko
LLLubica Lacinova
Lubica Lacinova
Maternal depression negatively affects the neurodevelopment of offspring, but its pharmacological treatment during gestation remains controversial. This study reports the consequences of maternal depression and/or prenatal antidepressant treatment with mirtazapine on offspring early neurodevelopment via an animal model of maternal depression induced by pregestational chronic unpredictable stress (CUS). Offspring from four groups were studied: nonstressed vehicle-treated dams, nonstressed mirtazapine-treated dams, stressed vehicle-treated dams, and stressed mirtazapine-treated dams. The hippocampal excitability of offspring was examined in primary hippocampal cultures established on the first postnatal day, reflecting mostly prenatal development, and in hippocampal slices prepared on postnatal days 11-13 reflecting an early postnatal development. Pregestational CUS modeling of maternal depression moderately suppressed offspring hippocampal excitability in primary cultures but facilitated it in slices. Mirtazapine administered to CUS-exposed dams partly rectified the changes observed in primary cultures of pups from untreated dams and, more prominently, in slices. Mirtazapine itself negatively affected the hippocampal excitability of nonstressed dam offspring in primary culture, and this effect was diminished in slices. Since altered hippocampal neurotransmission might be responsible, at least in part, for the neuropsychopathologies frequently observed in the offspring of depressed mothers, and mirtazapine was able partly relieve such changes, this treatment may be also beneficial during the prenatal and perinatal periods.